Overview

Study to Evaluate Pharmacokinetics, Food Effect, Safety and Efficacy of Oral Azacitidine

Status:
Completed
Trial end date:
2015-05-12
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to evaluate the pharmacokinetics of oral azacitidine when administered once daily as two 150-mg tablets, including the effect of food, and to evaluate the bioavailability of oral azacitidine 300-mg when administered as two 150-mg tablets relative to three 100-mg tablets.
Phase:
Phase 1
Details
Lead Sponsor:
Celgene
Celgene Corporation
Treatments:
Azacitidine